Relevant bibliographies by topics / Cattle – Vaccination

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Reports

Academic literature on the topic 'Cattle – Vaccination'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cattle – Vaccination.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cattle – Vaccination"

1

Rybnikář, A., E. Obořilová, and R. Hedbávný. "Efficacy Test of Trichoben Vaccine Administered to Calves at Different Intervals between Vaccination and Re-Vaccination." Acta Veterinaria Brno 77, no. 2 (2008): 239–43. http://dx.doi.org/10.2754/avb200877020239.

Full text
Abstract:
The aim of the study was to test a possible extension of the period between vaccination and revaccination with the live Trichoben vaccine (Bioveta, a.s., Czech Republic). The calves (n = 61) were vaccinated intramuscularly. The intervals between vaccination and re-vaccination were 3, 5, 7, 10, 14 or 28 days. Another group of calves (n = 16) was vaccinated once with a double dose of the vaccine. The protective immunity against experimental infection with a virulent Trichophyton verrucosum CCM F-650 strain was investigated in animals one month after the last vaccination and compared with a group of non-vaccinated controls (n = 16). Clinical results were evaluated and compared using balanced two-way-ANOVA. The level of post-vaccination immunity in cattle after re-vaccination was sufficient when the intervals were 5, 7, 10, 14 and 28 days. One-time injection of a double prophylactic dose of the vaccine and a 3-day interval between vaccinations reduced the immunity and vaccine efficacy to an unsatisfactory degree. There were significant differences between the groups of calves vaccinated using an interval longer than 5 days, and the group vaccinated once with a double dose, and the group with a 3-day interval between vaccinations. The level of post-vaccination immunity in cattle after re-vaccination at the commonly used interval of 10 - 14 days was identical with the immunity achieved when the interval was reduced to 5 or 7 days or extended up to 28 days. The extension of the interval between vaccinations to 5 - 28 days is recommended for using the Trichoben vaccine in veterinary practice.
APA, Harvard, Vancouver, ISO, and other styles
2

Hopker, Andy, Naveen Pandey, Rosie Bartholomew, Abigail Blanton, Sophie Hopker, Aniruddha Dhamorikar, Jadumoni Goswami, Rebecca Marsland, Prakash Metha, and Neil Sargison. "Livestock vaccination programme participation among smallholder farmers on the outskirts of National Parks and Tiger Reserves in the Indian states of Madhya Pradesh and Assam." PLOS ONE 16, no. 8 (August 27, 2021): e0256684. http://dx.doi.org/10.1371/journal.pone.0256684.

Full text
Abstract:
Effective livestock vaccination has the potential to raise prosperity and food security for the rural poor in low and middle income countries. To understand factors affecting access to vaccination services, and guide future policy, smallholder farmers in three locations in India were questioned about vaccination of their cattle and buffalo, with particular reference to foot and mouth disease (FMD), haemorrhagic septicaemia (HS) and blackquarter (BQ). In the three regions 51%, 50%, and 31% of respondents reported vaccinating their livestock; well below any threshold for effective population level disease control. However, within the third region, 65% of respondents in villages immediately surrounding the Kaziranga National Park reported vaccinating their cattle. The majority of respondents in all three regions were aware of FMD and HS, awareness of BQ was high in the Kanha and Bandhavgarh regions, but much lower in the Kaziranga region. The majority of respondents had positive attitudes to vaccination; understood vaccination protected their animals from specific diseases; and wished to immunise their livestock. There was no significant association between the age or gender of respondent and the immunisation of their livestock. Common barriers to immunisation were: negative attitudes to vaccination; lack of awareness of date and time of vaccination events; and difficulty presenting animals. Poor access to vaccination services was significantly associated with not vaccinating livestock. Fear of adverse reactions to vaccines was not significantly associated with not vaccinating livestock. Respondents who reported that vets or animal health workers (AHWs) were their main source of animal health knowledge were significantly more likely to have immunised their livestock in the last twelve months. Participants cited poor communication from vaccinators as problematic, both in publicising immunisation programmes, and explaining the purpose of vaccination. Where vaccinations were provided free of charge, farmers commonly displayed passive attitudes to accessing vaccination services, awaiting organised “immunisation drives” rather than seeking vaccination themselves. Based on these findings the following recommendations are made to improve participation and effectiveness of immunisation programmes. Programmes should be planned to integrate with annual cycles of: disease risk, agricultural activity, seasonal climate, social calendar of villages; and maximise efficiency for vaccinators. Dates and times of immunisation in each village must be well publicised, as respondents frequently reported missing the vaccinators. Relevant farmer education should precede immunisation programmes to mitigate against poor knowledge or negative attitudes. Immunisation drives must properly engage beneficiaries, particularly ensuring that services are accessible to female livestock keepers, and sharing some responsibilities with local farmers. Payment of a small monetary contribution by animal keepers could be considered to encourage responsibility for disease prevention, making vaccination an active process by farmers.
APA, Harvard, Vancouver, ISO, and other styles
3

BRAVO DE RUEDA, C., A. DEKKER, P. L. EBLÉ, and M. C. M. DE JONG. "Vaccination of cattle only is sufficient to stop FMDV transmission in mixed populations of sheep and cattle." Epidemiology and Infection 143, no. 11 (December 3, 2014): 2279–86. http://dx.doi.org/10.1017/s0950268814003033.

Full text
Abstract:
SUMMARYWe quantified the transmission of foot-and-mouth disease virus in mixed cattle-sheep populations and the effect of different vaccination strategies. The (partial) reproduction ratios (R) in groups of non-vaccinated and vaccinated cattle and/or sheep were estimated from (published) transmission experiments. A 4 × 4 next-generation matrix (NGM) was constructed using these estimates. The dominant eigenvalue of the NGM, the R for a mixed population, was determined for populations with different proportions of cattle and sheep and for three different vaccination strategies. The higher the proportion of cattle in a mixed cattle-sheep population, the higher the R for the mixed population. Therefore the impact of vaccination of the cattle is higher. After vaccination of all animals R = 0·1 independent of population composition. In mixed cattle-sheep populations with at least 14% of cattle, vaccination of cattle only is sufficient to reduce R to < 1.
APA, Harvard, Vancouver, ISO, and other styles
4

Campo, M. Saveria. "Vaccination against papillomavirus in cattle." Clinics in Dermatology 15, no. 2 (March 1997): 275–83. http://dx.doi.org/10.1016/s0738-081x(96)00165-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jones, Trevor O. "Vaccination of cattle against TB." Veterinary Record 175, no. 12 (September 25, 2014): 308.1–308. http://dx.doi.org/10.1136/vr.g5841.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Richeson, John T., Heather D. Hughes, Paul R. Broadway, and Jeffery A. Carroll. "Vaccination Management of Beef Cattle." Veterinary Clinics of North America: Food Animal Practice 35, no. 3 (November 2019): 575–92. http://dx.doi.org/10.1016/j.cvfa.2019.07.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lazarus, David Dazhia, Yiltawe Simwal Wungak, Mohammed Ignatius Adah, John Okpapi Ibu, Jerry Ngutor Abenga, Pius Stephen Ekong, and Hussaini Gulak Ularamu. "Serological response of commercial dairy cattle to inactivated foot-and-mouth disease vaccine (type-O & A) in Nigeria." Asian Journal of Medical and Biological Research 1, no. 2 (November 23, 2015): 163–68. http://dx.doi.org/10.3329/ajmbr.v1i2.25606.

Full text
Abstract:
An observational study was conducted in a peri-urban dairy establishment in Jos South, Plateau State Nigeria to determine immune response of dairy cattle to commercial inactivated foot-and-mouth disease vaccine serotypes (O and A). Thirty seven Friesian cattle aged ?2years old with their crosses (15 selected pre-vaccination and 22 selected 21 days post-vaccination) were investigated for immune response to vaccination with an inactivated trivalent FMD vaccine containing serotypes O, A and SAT 2). Sera collected on day 0 pre-vaccination and 21 days post-vaccination was tested for structural protein antibodies to FMD serotypes O and A using the Solid Phase Competitive ELISA assay. The mean OD value for serum end point titre of FMD serotype O pre-vaccination was 11.64% with 6.67% (95%CI: 0.33 – 28.73) of the selected cattle being seropositive, at 21 days post-vaccination the mean OD value in selected cattle was 52.83% with 68.18% (95%CI: 46.95 – 84.89) of the selected cattle seropositive. For the FMD serotype A, 26.67% (95%CI: 9.10 – 52.53) of the selected cattle were seropositive pre-vaccination with a mean OD value of 29.21% and by 21 days post-vaccination, 72.73% (95%CI: 51.67 – 88.13) of the selected cattle were seropositive with a mean OD value of 61.70%. Serological response to vaccination improved in most selected cattle by 21 days post-vaccination. This study result has indicated that commercial inactivated FMD vaccines used for the prophylactic control of FMD in commercial dairy farm in Nigeria provoked immune response after a single shot.Asian J. Med. Biol. Res. June 2015, 1(2): 163-168
APA, Harvard, Vancouver, ISO, and other styles
8

KAO, R. R., and M. G. ROBERTS. "A comparison of wildlife control and cattle vaccination as methods for the control of bovine tuberculosis." Epidemiology and Infection 122, no. 3 (June 1999): 505–19. http://dx.doi.org/10.1017/s0950268899002472.

Full text
Abstract:
The Australian brushtail possum is the major source of infection for new cases of bovine tuberculosis in cattle in New Zealand. Using hypothetical values for the cost of putative cattle and possum Tb vaccines, the relative efforts required to eradicate Tb in cattle using possum culling, possum vaccination or cattle vaccination are compared. For realistic assumed costs for 1080 poison bait, possum culling is found to be a cost-effective strategy compared to cattle vaccination if the required control area is below 13 ha per cattle herd, while possum vaccination is cost-effective for control areas of less than 3 ha per herd. Examination of other considerations such as the possible roles of possum migration and heterogeneities in possum population density suggest that each control strategy may be superior under different field conditions. Finally, the roles of the possum in New Zealand, and the Eurasian badger in Great Britain and Ireland in the transmission of bovine tuberculosis to cattle are compared.
APA, Harvard, Vancouver, ISO, and other styles
9

Olsen, Steven C., Lauren S. Crawford, Antonio Fuentes, Miladin Kostovic, and Paola M. Boggiatto. "Influence of species of negative control sera on results of a brucellosis fluorescence polarization assay." Journal of Veterinary Diagnostic Investigation 33, no. 1 (November 19, 2020): 67–72. http://dx.doi.org/10.1177/1040638720970888.

Full text
Abstract:
We evaluated serologic responses of cattle, bison, elk, and swine representing negative control, early vaccination (4–8 wk), late vaccination (21–28 wk) or booster vaccination, early after-experimental challenge (2–4 wk), and late after-experimental challenge (8–21 wk), in a brucellosis fluorescence polarization assay (FPA; n = 10 sera per species per treatment) using negative control sera from cattle, bison, elk, and swine ( n = 5 per species). Sera from cattle shedding Brucella abortus strain RB51 in milk were also evaluated against the 20 negative control sera. The species of negative control sera used in the FPA could increase ( p < 0.05) delta millipolarization (mP; delta mP = sample mP − negative control mP) results. In general, the species of negative control sera did not alter the interpretation of FPA results in control, vaccinated, or infected animals. Even after repeated RB51 vaccinations in bison, cattle, or elk, or in cattle shedding RB51 in milk, serologic results from the FPA remained negative. Species differences in FPA results were noted; elk developed robust humoral responses very quickly after infection that resulted in strong positive FPA results. In cattle and bison, humoral responses appeared to develop over a longer period of time, and greater delta mP values were detected at later times after infection. Sensitivity of the FPA for detecting infected animals was greatest for elk in early challenge samples and bison in late challenge samples. Our data suggest that species of origin of negative control sera does not influence interpretation of the FPA in natural hosts of Brucella abortus.
APA, Harvard, Vancouver, ISO, and other styles
10

Aamodt, O., B. Naess, and O. Sandvik. "Vaccination of Norwegian Cattle against Ringworm." Zentralblatt für Veterinärmedizin Reihe B 29, no. 6 (May 13, 2010): 451–56. http://dx.doi.org/10.1111/j.1439-0450.1982.tb01247.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cattle – Vaccination"

1

Wright, Ashley D. "Clostridial Diseases of Cattle." College of Agriculture, University of Arizona (Tucson, AZ), 2016. http://hdl.handle.net/10150/625416.

Full text
Abstract:
4 pp.
Vaccinating for clostridial diseases is an important part of a ranch health program. These infections can have significant economic impacts on the ranch due to animal losses. There are several diseases caused by different organisms from the genus Clostridia, and most of these are preventable with a sound vaccination program. Many of these infections can progress very rapidly; animals that were healthy yesterday are simply found dead with no observed signs of sickness. In most cases treatment is difficult or impossible, therefore we rely on vaccination to prevent infection. The most common organisms included in a 7-way or 8-way clostridial vaccine are discussed below. By understanding how these diseases occur, how quickly they can progress, and which animals are at risk you will have a chance to improve your herd health and prevent the potential economic losses that come with a clostridial disease outbreak.
APA, Harvard, Vancouver, ISO, and other styles
2

Nobiron, Isabelle. "DNA vaccination against bovine viral diarrhoea virus in mice and cattle." Thesis, Royal Veterinary College (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Knight-Jones, Theo. "Field evaluation of foot-and-mouth disease vaccination in Turkey." Thesis, Royal Veterinary College (University of London), 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.618321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Horne, Willy J. "Application of vaccination protocols to manage beef cattle productivity and mitigate production risk." [College Station, Tex. : Texas A&M University, 2009. http://hdl.handle.net/1969.1/ETD-TAMU-2009-05-561.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Biswal, Jitendra Kumar. "Evaluation of mucosal immunity in FMDV vaccinated and infected cattle." Thesis, Royal Veterinary College (University of London), 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.572448.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Walters, Adam Alexander. "The development and evaluation of a nanoparticulate antigen delivery system for vaccination of cattle." Thesis, University of Surrey, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.600038.

Full text
Abstract:
Conventional subunit vaccine regimes can be modified in order to stimulate strong immune responses resulting in memory cell formation. An adjuvant system that has gained increased attention in recent years is the use of particulate antigen delivery. Particulate systems have a number of advantages over conventional approaches since they are believed to be taken up preferentially by dendritic cells (DC) where they prolong the release of antigen resulting in enhanced T cell stimulation. Furthermore, they offer a versatile system that allows for targeted delivery of antigen and adjuvant to the same DC. A wide range of particle types have been used to enhance vaccine potency. Poly (Iactic-co-glycolic) acid (PLGA), in particular, has been used successfully by many groups. However, there are a great variety of means to synthesise and characterise the desired particles. This study, firstly, set out to develop and optimise a protocol to generate nanoparticles with defined properties. A number of parameters were evaluated including, particle size, protein loading, protein coating and surface charge. In addition to conventional methods, such as electron microscopy and dynamic light scattering, particles were characterised by novel flow cytometric methods. While particles have been shown to adjuvant candidate vaccine proteins, this property should be enhanced when the particle is targeted to dendritic cells by increasing specific uptake. Specific targeting has previously been performed through either targeting with natural receptor ligands or monoclonal antibodies. However, there is currently conflicting data in other studies as to whether this can be achieved. It was thus the second objective of this study to devise methods to implement this technology and to determine whether targeting can be achieved through either approach. It was 1 Abstract found that there was potential in targeting DC populations with monoclonal antibodies, while targeting with natural ligands yielded more mixed results. As a final component, the adjuvant properties of the particles rationally loaded with antigens and molecular adjuvant was tested in vivo in cattle using a viral challenge model. The experiment had a promising outcome with the vaccine particles inducing both T cell and antibody responses resulting in a degree of protection against virus challenge. Furthermore, it highlighted areas where the system, both the particles and the model, may be improved, which could form the basis of future work.
APA, Harvard, Vancouver, ISO, and other styles
7

Edacheril, Mathew. "Assessment of herd immunity to foot-and-mouth disease." Thesis, University of Reading, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.314315.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

MacMillan, Alastair. "The bovine immune response following Brucella vaccination and infection and the development of a discriminatory test." Thesis, University of Surrey, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.313252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wagner, Richard Tucker. "Assessment of On-Arrival Vaccination and Deworming on Health and Growth Performance in High Risk Stocker Cattle." Thesis, Mississippi State University, 2019. http://pqdtopen.proquest.com/#viewpdf?dispub=10979232.

Full text
Abstract:

The study objective was to evaluate the effects of vaccination (respiratory and clostridial vaccination or no vaccination) and deworming (fenbendazole and levamisole or no deworming) of high risk stocker calves on-arrival on health and growth performance. Eighty sale barn origin calves were purchased three separate years (n = 240) from local order buyer. Steers (n = 61) and bulls (n = 179) were received over three days (d –3 to –1). On d 0 calves were stratified by arrival BW and FEC into 20 pens of 4 calves each, and treatment was applied to pens in 2 x 2 factorial. Vaccination increased the likelihood of BRD 1.7 times (P = 0.07) versus calves not vaccinated. Vaccination did not affect gain, but calves receiving dewormer had greater ADG than those not receiving dewormer. Calves that arrived uncastrated or with high fever (≥ 40.0 °C) gained less and were 1.7 and 4.3 times more likely (P < 0.10) to be treated for disease, respectively.

APA, Harvard, Vancouver, ISO, and other styles
10

Witchell, J. "Cytokine gene and protein expression in BCG vaccinated and non-vaccinated Mycobacterium bovis infected cattle." Thesis, University of Hertfordshire, 2009. http://hdl.handle.net/2299/3637.

Full text
Abstract:
The persistent increase of bovine tuberculosis (bTB) over the past twenty years has put a substantial strain on both the British economy and the welfare of livestock. However, the development of an effective bTB vaccine has been continually hindered by the lack of knowledge on the immune response following Mycobacterium bovis (M. bovis) infection. In collaboration with the TB Research Group at the Veterinary Laboratories Agency (VLA, Surrey), this thesis is part of a much wider strategy managed by the Department of Environment, Food and Rural Agency (DEFRA) aimed at elucidating the immunopathogenesis of M. bovis and to develop more effective infection control measures. The specific focus of this thesis was to enable a stronger understanding of the bovine immune response over different periods of M. bovis infection and to apply this new knowledge in evaluating the efficacy of a novel BCG vaccination. Time Course Study: Knowledge of time dependent cytokine expression following M. bovis infection would aid vaccine development by revealing potential correlates of protection. Interferon gamma (IFN-γ), tumour necrosis factor alpha (TNF-α), interleukin (IL) 4 and 10 expression were analysed using quantitative (q) PCR in formalin fixed bovine lymph nodes following five, twelve and nineteen weeks of M. bovis infection. A strong pro-inflammatory/ T helper 1 (TH1) lymphocyte response was evident at five weeks post M. bovis infection, represented by IFN-γ and TNF-α expression (log2 copies of 6.5 and 2.15, respectively) in the absence of IL4. Between five and twelve weeks of infection, a significant increase was observed in IL10 (log2 copies from 5.97 to 8.27, p<0.01, Mann Whitney test), accompanied by an increase in both IFN-γ (log2 7.53) and TNF-α (log2 3.94). This data conformed to a recently described aspect of TH1 lymphocytes, a ‘self-limiting’ nature in which cells produced both IFN-γ and IL10 with the aim of controlling the heightened pro-inflammatory response. The role of IL10 as an immunosuppressive became evident when comparing cytokine expression between four different types of thoracic lymph node; the left bronchial (LB), cranial mediastinal (CRM), caudal mediastinal (CM) and cranial tracheobronchial (CRT) nodes. The LB and CRM lymph nodes produced significantly higher levels of IFN-γ expression (log2 copies between 8.2 and 10) as compared to the CM and CRT (log2 copies between 2.6 and 5.5, p<0.001, Mann Whitney test). Further analysis of the data as a profile of cytokine expression for each lymph node type revealed that IFN-γ was dominantly expressed within the LB and CRM nodes, whereas within the CM and CRT nodes, IL10 was the dominant cytokine. The former nodes also displayed a higher level of pathological damage (represented by mean percentage area coverage of granuloma, 33.6 and 20%, respectively) as compared to the CM (13%) and the CRT lymph node types (10.8 %). This suggests conflicting roles for IFN-γ and IL10 in the development of immune-associated pathology. Following nineteen weeks of infection, the expression levels of IFN-γ, TNF-α and IL10 reduced (log2 6.22, 3.02 and 7.03, respectively) implying a loss of the cellular response. The later stages of bovine tuberculosis have been shown within the literature to display characteristics of a humoral rather than cell mediated response. However, within this study at nineteen weeks post infection IL4 (an important cytokine in the development of the humoral response) remained undetectable. The results from this study therefore confirm the importance of the cell mediated immune profile in response to M. bovis infection as well as the integral role of IFN-γ in both protection and pathology. It also further demonstrates the involvement of IL10 in controlling the IFN-γ response and highlights this cytokine as being potentially important in future immunologybased vaccination studies. BCG Vaccination Study: The current vaccine used against human tuberculosis, BCG, has provided variable results on protection against infection in experimental bovine studies. The BCG bacterium has lost a comparatively large quantity of genomic DNA through attenuation since its primary production in 1921, of which the majority represented genes encoding antigenic proteins. MPB70 and MPB83 are differentially expressed between BCG sub-strains due to a single nucleotide polymorphism in the alternative sigma factor K (SigK). BCG Pasteur has been shown to produce low levels of these antigenic proteins; however complementation of BCG Pasteur with a copy of sigK from BCG Russia resulted in up-regulating expression. It was therefore hypothesised that the recombinant BCG (sigK) Pasteur would prove more efficient in controlling M. bovis infection by inducing a stronger protective immune response post vaccination. IFN-γ, TNF-α, IL 4 and 10 expression were analysed using qPCR within the freshly dissected lymph nodes of five experimental cattle groups; BCG Pasteur vaccinated M. bovis challenged, BCG (sigK) Pasteur vaccinated challenged, non-vaccinated infected, non-vaccinated noninfected and BCG Pasteur vaccinated non-infected. Five weeks following infection, a strong IFN-γ mRNA response was detected in both the non-vaccinated and vaccinated cattle (mean log2 copies between 9.6 and 10.5 as compared to between 7.84 and 8.58 in the non-infected cattle). M. bovis infection also induced a significant reduction in IL10 mRNA levels in both vaccinated and non-vaccinated cattle (mean log2 14.4 in the infected groups compared to 15.5 in the non-infected cattle, p<0.005, Mann Whitney test) although there was little difference in TNF-α expression (mean log2 copies between 11.06 and 11.8 in all five groups). Interestingly, IL4 mRNA was detectable only within the two non-infected control groups (mean log2 12.4), further supporting the concept of a strong cell mediated response after five weeks of infection. Vaccination prior to challenge had an effect on IFN-γ mRNA levels only, as both the BCG Pasteur and BCG (sigK) Pasteur vaccinated groups displayed a smaller increase in IFN-γ mRNA following challenge (mean log2 10.3 and 9.6, respectively) as compared to the nonvaccinated group (mean log2 10.5). This reflected the role of vaccination in priming the immune response to enable more rapid elimination of the bacteria and subsequently inducing a lesser pro-inflammatory response. Interestingly, the BCG Pasteur vaccinated group appeared to control the immune response to a greater extent, as IFN-γ mRNA was significantly similar to that observed in the non-vaccinated non-infected group (mean log2 8.58, p>0.05, Mann Whitney test). In addition to the qPCR data, levels of IFN-γ and TNF-α protein (represented by the number of cells producing these proteins) were also analysed by immunohistochemistry. IFN-γ protein in the five experimental groups displayed the same pattern as that observed for IFN-γ mRNA expression (p<0.001, Spearmans correlation coefficient). However, analysis of TNF-α protein revealed significant differences between the five groups (p<0.005, Kruskal Wallis test) in contrast to that observed for the mRNA levels (p>0.05, Spearmans correlation coefficient) suggesting that posttranscriptional controls may play an important role in TNF-α translation. The difference in IFN-γ mRNA and protein expression between the two vaccination groups was also reflected within the pathological data. Although both BCGs reduced levels to below that of the non-vaccinated group (represented by mean percentage area coverage of granuloma, 59%), the BCG Pasteur group displayed less pathology (mean 6%) compared to the BCG (sigK) Pasteur cattle (mean 35%). It was suggested that the increased antigenic repertoire of the recombinant BCG (sigK) Pasteur did result in a stronger stimulation of the immune response post vaccination but that, as a consequence the bacterial threat was eliminated more rapidly.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Cattle – Vaccination"

1

US DEPARTMENT OF AGRICULTURE. Eradicating cattle brucellosis. [Washington, D.C.]: U.S. Dept. of Agriculture, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Provost, A. Production of freeze-dried pleuropneumonia vaccine, and a mixed rinderpest-pleuropneumonia vaccine at the Central Veterinary Laboratory at Bamako, Republic of Mali. Karachi, Pakistan: Published for the OICD, APHIS, U.S. Dept. of Agriculture by Mrs. Geti Saad, Muhammad Ali Society, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Robertsson, Jan Ake. Salmonella infections in cattle: Cellular and hormonal immune reactivity against O-antigens and porins afterinfection and vaccination with killed and live vaccines. Uppsala: Sveriges Lantbruksuniversitet, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Provost, Alain. Production of freeze-dried pleuropneumonia vaccine, and a mixed rinderpest-pleuropneumonia vaccine at the Central Veterinary Laboratory at Bamako, Republic of Mali. Karachi, Pakistan: Published for the OICD, APHIS, United States Dept. of Agriculture by Mrs. Geti Saad, Muhammad Ali Society, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Oral, M. Comparative studies of immunity in Turkish cattle vaccinated with native and foreign originated different foot-and-mouth disease vaccines =: Turkiyede kullanilan yerli ve yabanci menseli sap asilarinin bagisiklik gucleri uzerine karsilastirmali bir arastirma. Karachi, Pakistan: Muhammad Ali Society, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Segall, Thomas. Vaccination against salmonella infection in cattle: An immuno-pathological and bacteriological study of calves orally immunized with live vaccines. Uppsala: Sveriges Lantbruksuniversitet, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mark, Nicholson. South West Mau Forest ECF control: Destocking, paraveterinary training, livestock extension, and fencing requirements for the proposed resettlement schemet [i.e. scheme]. Nairobi: Centre for Biodiversity, National Museums of Kenya, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mitsarā. Manual for the production of anthrax and blackleg vaccines. Rome: Food and Agriculture Organization of the United Nations, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Matchett, Arnett. Vaccinating cattle against brucellosis. [s.l.]: United States Departmentof Agriculture. Veterinary Services, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight. USDA licensing of a genetically altered veterinary vaccine: Joint hearing before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology and the Subcommittee on Department Operations, Research, and Foreign Agriculture of the Committee on Agriculture, House of Representatives, Ninety-ninth Congress, second session, April 29, 1986. Washington: U.S. G.P.O., 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Cattle – Vaccination"

1

Campo, M. S. "Vaccination Against Papillomavirus in Cattle." In Current Topics in Microbiology and Immunology, 255–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78487-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cortese, Victor. "Immunology and Vaccination of Dairy Cattle." In Dairy Production Medicine, 165–73. Oxford, UK: Blackwell Publishing Ltd., 2011. http://dx.doi.org/10.1002/9780470960554.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Smith, David R. "Vaccination of Cattle against Escherichia coli O157:H7." In Enterohemorrhagic Escherichia coli and Other Shiga Toxin-Producing E. coli, 487–501. Washington, DC, USA: ASM Press, 2015. http://dx.doi.org/10.1128/9781555818791.ch25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Campo, M. Saveria, and William F. H. Jarrett. "Vaccination Against Cutaneous and Mucosal Papillomavirus in Cattle." In Ciba Foundation Symposium 187 - Vaccines Against Virally Induced Cancers, 61–77. Chichester, UK: John Wiley & Sons, Ltd., 2007. http://dx.doi.org/10.1002/9780470514672.ch5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

McGarvie, G. M., L. M. Chandrachud, J. M. Gaukroger, G. J. Grindlay, B. W. O’Neil, J. W. Baird, E. R. Wagner, W. F. H. Jarrett, and M. S. Campo. "Vaccination of Cattle with L2 Protein Prevents BPV-4 Infection." In Immunology of Human Papillomaviruses, 283–90. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2449-6_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cortese, V. "Immunology and vaccination of dairy cattle." In Large Dairy Herd Management, 1087–92. American Dairy Science Association, 2017. http://dx.doi.org/10.3168/ldhm.1278.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mukolwe, Donald Lubembe, Charles Byaruhanga, and Fredrick Ojiambo Obonyo. "Epidemiology and Economic Importance of Tick-Borne Diseases of Cattle in Africa." In Advances in Environmental Engineering and Green Technologies, 144–65. IGI Global, 2021. http://dx.doi.org/10.4018/978-1-7998-6433-2.ch007.

Full text
Abstract:
The tropical and sub-tropical climate in Africa favours multiplication and maintenance of tick vectors and transmission of various pathogens to cattle. Key challenges including acaricide resistance, policy issues, transboundary animal movements, and inadequate veterinary services compromise effective control of tick-borne diseases (TBDs). This chapter discusses important host, pathogen, climatic, and management factors that impact the control of TBDs among cattle in Africa, and which affect the productivity and overall contribution to economic development. The economic losses in cattle production attributed to tick infestation and TBDs in Africa are also reviewed. The use of a sustainable integrated control approach, including vaccination, strategic tick control, surveillance for acaricide resistance, and multi-stakeholder involvement is also evaluated.
APA, Harvard, Vancouver, ISO, and other styles
8

Waruri, Sebastian Kironji, James Muriuki Wanjohi, Leonard Khaluhi, Sam Ndungu Gichuhi, and Erick O. Mungube. "Bovine Anaplasmosis and Control." In Advances in Environmental Engineering and Green Technologies, 221–42. IGI Global, 2021. http://dx.doi.org/10.4018/978-1-7998-6433-2.ch010.

Full text
Abstract:
Bovine anaplasmosis is one of the most important tick borne diseases of ruminants worldwide causing significant economic losses in the livestock industries due to the high morbidity and mortality in susceptible cattle herds. Bovine anaplasmosis, caused by Anaplasma marginale, is an infectious but non-contagious disease. The mode of transmission of bovine anaplasmosis includes mechanical (blood contaminated fomites (needles, ear tagging, dehorning and castration equipment), biological (tick bites) and transplacental (mother to fetus). Bovine Anaplasmosis occurs in tropical and subtropical regions worldwide. Cattle of all ages are susceptible to infection with A. marginale, but the severity of disease increases with age. The common clinical sign of bovine anaplsmosis includes; fever, anorexia, rapid loss of body condition, severe decrease in milk production, pale and icteric mucous membranes, increased heart and respiratory rates, muscle weakness and depression. Diagnosis of bovine anaplasmosis can be made by demonstration of A. marginale on stained blood smears from clinically infected animals during the acute phase of the disease, but it is not reliable for detecting infection in pre-symptomatic or carrier animals. Instead, serological demonstration of antibodies and confirmation of antigen with molecular detection tools are used for diagnosis. Anaplasmosis can be treated by administration of oxytetracyclines, however oxytetracyclines do not clear the parasite from carrier animals. Control measures for bovine anaplasmosis vary with geographical location and include maintenance of Anaplasma free herds, vector control, administration of antibiotics and vaccination. Intensive acaridae application to control ticks has a number of limitations, therefore, immunization together with strategic tick control is recommended for exotic and crossbred cattle. Further studies on epidemiology of bovine anaplasmosis is needed
APA, Harvard, Vancouver, ISO, and other styles
9

William Tong, C. Y. "Vaccine-Preventable Diseases." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0024.

Full text
Abstract:
These are diseases in which an effective preventive vaccine exists. A death that could have been prevented by vaccination is a vaccine- preventable death. The World Health Organization (WHO) has identified twenty-five diseases as vaccine preventable. This list may expand as new vaccines are being developed. The Expanded Programme on Immunization, or EPI, is vaccination programme introduced in 1974 by the WHO to all nations. The EPI initially targeted diphtheria, whooping cough, tetanus, measles, poliomyelitis, and tuberculosis. The aim was to provide universal immunization for all children by 1990 and to achieve health for all by 2000. In 2010, about 85% of children under one year of age in the world had received at least three doses of DTP vaccine (diphtheria, tetanus, and polio). Additional vaccines have now been added to the original six targets. Most countries have now added Hepatitis B (not in UK) and Haemophilus influenzae type b (Hib) to their routine infant immunization schedules, and an increasing number are in the process of adding pneumococcal conjugate vaccine and rotavirus vaccines to their schedules. Immunization is a proven tool for controlling and even eradicating infectious diseases. The immunization campaign against smallpox between 1967 and 1977 resulted in the eradication of smallpox. Apart from smallpox, the only other viral infection that was declared eradicated through vaccination campaign was rinderpest in cattle (2011), a close relative of measles virus in humans. Another major infection target for global eradication is against poliomyelitis—the global polio eradication initiative (GPEI). When the programme began in 1988, polio threatened 60% of the world’s population. Eradication of poliomyelitis is now within reach: infections have fallen by 99%; wild type polio type 2 was last detected in 1999 and declared eradicated in 2015; wild-type poliovirus type 3 has not been detected in the world since 2012. Poliovirus type 1 is the only wild- type virus in circulation and endemic transmission is only reported in Afghanistan and Pakistan. Currently, the old trivalent oral poliovirus vaccine is replaced by the more potent bivalent poliovirus type 1 and 3 vaccine. Many western countries have switched from oral vaccine to the injected inactivated vaccine to avoid the problem of vaccine- induced paralysis, which could be associated with the oral live attenuated vaccine.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cattle – Vaccination"

1

Ibarburu, Maro A., Beth E. Doran, and J. D. Lawrence. Valuing Double Vaccination in Feeder Cattle. Ames (Iowa): Iowa State University, January 2005. http://dx.doi.org/10.31274/ans_air-180814-1119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Johnson, Anna K., Dana K. Buer, Melissa A. Culbertson, Caitlyn A. Dierks, Hannah K. Schroeder, Brittney Yehling, Theresa P. Johnson, and Marshall V. Ruble. Evaluation of the Effect of Vaccination Side on Subsequent Halter Breaking Side Preference in Cattle. Ames (Iowa): Iowa State University, January 2014. http://dx.doi.org/10.31274/ans_air-180814-1143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kramer, Luke M., Mary S. Mayes, Jazmine Brown, Lyle Braun, Eric R. Fritz-Waters, Jamie Williams, Amelia Woolums, Christopher Chase, and James M. Reecy. Evaluation of Responses to Vaccination of Angus Cattle for Four Viruses that Contribute to Bovine Respiratory Disease Complex. Ames (Iowa): Iowa State University, January 2017. http://dx.doi.org/10.31274/ans_air-180814-497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kramer, Luke M., Mary S. Mayes, Jazmine Brown, Lyle Braun, Eric R. Fritz-Waters, Jamie Williams, Amelia Woolums, Christopher Chase, and James M. Reecy. Evaluation of Responses to Vaccination of Angus Cattle for Four Viruses that Contribute to Bovine Respiratory Disease Complex. Ames: Iowa State University, Digital Repository, 2017. http://dx.doi.org/10.31274/farmprogressreports-180814-2095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cattle – Vaccination' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography